Loading...
Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis. The kinase inhibitor nintedanib specific for vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and fibroblast growth factor receptor (FGFR) significan...
Saved in:
| Published in: | Respir Res |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4273482/ https://ncbi.nlm.nih.gov/pubmed/25496490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-014-0157-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|